3 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease (NILVAD)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2016,
Alzheimer’s disease (AD) is an ever-increasing public health concern among the aging population and is the most common form of dementia affecting more than 15 million individuals worldwide and around 5 million Europeans. The direct and indirect costs of AD and other dementias amount to more than €440,000 million each year (www.alz.org, 2010).Even modest therapeutic advances that delay disease onse ...
Voir le projet
17
Participants partenaires
TERMINÉ
WINTHERapeutics: development of a systems biology method to predict efficacy of cancer drugs to optimize individualized therapeutic decision and improve clinical outcome for cancer patients (WINTHER)
Date du début: 1 mars 2013, Date de fin: 28 févr. 2015,
Relevance: WINTHER project focuses on the development and validation, in 24 months, of industry supported new tools and computational methods, to predict efficacy of drugs in cancer patientsCurrent medical needs: Selection of cancer targeted therapies based on molecular abnormalities (mutations /amplifications/ translocations) benefit today only to 10-40% of patients. For the remaining majority, ...
Voir le projet
12
Participants partenaires
TERMINÉ
Atomic QUantum TEchnologies (AQUTE)
Date de fin: 1 févr. 2010,
... many-particle atomic systems are employed to realize special-purpose quantum processors, for instance quantum simulators.Groundbreaking work in qualitatively new directions is also needed to lay the foundations for the future attainment of scalable fault-tolerant architectures. AQUTE will thus also* investigate new experimental systems that have become available in the laboratory and are of direc ...
Voir le projet